Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast for Dry Eye in Contact Lens Wearers
NCT03431272Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lifitegrast in contact lens-induced dry eye (CLIDE), sponsored by University of Alabama at Birmingham. Planned start Nov 2018; status: withdrawn.
02
Drugs
lifitegrast
03
Conditions
contact lens-induced dry eye (CLIDE)
Beyond the preview
Go deeper on NCT03431272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431272.